Log In
BCIQ
Print this Print this
 

Immucyst

  Manage Alerts
Collapse Summary General Information
Company Alliance Pharma plc
DescriptionConnaught strain of Bacillus Calmette-Guerin (BCG)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationBladder cancer
Indication DetailsTreat and prevent non muscle invasive bladder cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$25.6M

$22.3M

$3.3M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/01/2010

$25.6M

$22.3M

$3.3M

Get a free BioCentury trial today